Cargando…

Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia

BACKGROUND: The clinical significance of miR-17 in patients with acute myeloid leukemia (AML) remains unknown. METHODS: Real-time quantitative reverse transcription-polymerase chain reaction (qPCR) was performed to detect the miR-17 expression in 115 de novo AML patients, 31 patients at complete rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yang, Liu, Yue, Shang, Limei, Chen, Huijuan, Yue, Yanhua, Dong, Weimin, Guo, Yanting, Yang, Haonan, Yang, Xiaojun, Liu, Yan, Gu, Weiying, Zhang, Xiaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209371/ https://www.ncbi.nlm.nih.gov/pubmed/35536524 http://dx.doi.org/10.1007/s10147-022-02161-5

Ejemplares similares

High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia
por: Liu, Yue, et al.
Publicado: (2023)

Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia
por: Yang, Lan, et al.
Publicado: (2018)

Successful Treatment of a Patient with Chronic Myelogenous Leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature Review
por: Yue, Yanhua, et al.
Publicado: (2020)

Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia
por: Guo, Chao, et al.
Publicado: (2020)

Overexpression of Prohibitin 2 Protein is Associated with Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia
por: Lee, Young Eun, et al.
Publicado: (2022)

Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia
por: Shi, Jin-long, et al.
Publicado: (2015)

KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia
por: Zhou, Jing-Dong, et al.
Publicado: (2017)

Identification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Myeloid Leukemia
por: Zhi, Feng, et al.
Publicado: (2013)

Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia
por: Tang, Xiaoqiong, et al.
Publicado: (2015)

ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia
por: Li, Ran, et al.
Publicado: (2022)

Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia
por: Han, Yixiang, et al.
Publicado: (2014)

HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia
por: Zhang, Xiaoning, et al.
Publicado: (2022)

H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia
por: Zhang, Ting-juan, et al.
Publicado: (2018)

Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish
por: Lu, J-W, et al.
Publicado: (2017)

DLC1 deficiency at diagnosis predicts poor prognosis in acute myeloid leukemia
por: Li, Xueqian, et al.
Publicado: (2022)

High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2017)

Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia
por: Lin, Yan, et al.
Publicado: (2019)

Summed rest score in gated myocardial perfusion imaging is a good predicator for treatment-related cardiotoxicity after anthracycline chemotherapy in patients with diffuse large B-cell lymphoma
por: Lin, Yan, et al.
Publicado: (2020)

Leukemia Stem Cell-Released Microvesicles Promote the Survival and Migration of Myeloid Leukemia Cells and These Effects Can Be Inhibited by MicroRNA34a Overexpression
por: Wang, Yue, et al.
Publicado: (2016)

PRICKLE1, a Wnt/PCP signaling component, is overexpressed and associated with inferior prognosis in acute myeloid leukemia
por: Jiang, Duanfeng, et al.
Publicado: (2021)

LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia
por: Guo, Chao, et al.
Publicado: (2020)

SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia
por: Gu, Yu, et al.
Publicado: (2022)

Role of CD19 and specific KIT‐D816 on risk stratification refinement in t(8;21) acute myeloid leukemia induced with different cytarabine intensities
por: Wang, Biao, et al.
Publicado: (2020)

Cytogenetic characteristics of and prognosis for acute myeloid leukemia in 107 children
por: Chen, Wanzi, et al.
Publicado: (2021)

A 17-gene-expression profile to improve prognosis prediction in childhood acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2018)

BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia
por: Zhou, Jing-dong, et al.
Publicado: (2019)

Up-Regulation of TRIM32 Associated With the Poor Prognosis of Acute Myeloid Leukemia by Integrated Bioinformatics Analysis With External Validation
por: Xu, Xiaoyan, et al.
Publicado: (2022)

Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia
por: Liu, Yong, et al.
Publicado: (2023)

Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia
por: Li, Guilan, et al.
Publicado: (2020)

Prognostication refinement in NPM1‐mutated acute myeloid leukemia stratified by FLT3‐ITD status with different induction doses of cytarabine
por: Wang, Biao, et al.
Publicado: (2023)

Novel myeloma patient-derived xenograft models unveil the potency of anlotinib to overcome bortezomib resistance
por: Yue, Yanhua, et al.
Publicado: (2022)

High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2016)

Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia
por: Chen, Si-Liang, et al.
Publicado: (2020)

Fatty acid metabolism predicts prognosis and NK cell immunosurveillance of acute myeloid leukemia patients
por: Ye, Zhitao, et al.
Publicado: (2022)

HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia
por: Zhou, Xiaojia, et al.
Publicado: (2020)

Expression and prognosis of the B7 family in acute myeloid leukemia
por: Zhang, Wei, et al.
Publicado: (2021)

High expression of dedicator of cytokinesis 1 adversely influences the prognosis of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
por: Zhang, Gaoqi, et al.
Publicado: (2019)

The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias
por: Paolillo, Rosa, et al.
Publicado: (2022)

CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
por: Wang, Jinghua, et al.
Publicado: (2018)

Poor Prognosis in Acute Myeloid Leukemia Patients with Monosomal Karyotypes
por: Xu, Junqing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t2fna532begg9bi2pa6gbn6ov7